Each BIFILAC capsule contains
BIFILAC HP contains, Streptococcus faecalis T-110, Clostridium butyricum TO-A, Bacillus mesentericus TO-A which are patented strains, licensed from TOA Pharmaceuticals Co. ltd, Japan and Lactic acid bacillus (Lactobacillus sporogenes), which is a time tested probiotic strain. Through their symbiotic action they produce certain pathogen (Bad bacteria) inhibiting factors and in addition also produce a bifidogenic nutrient which helps in increasing the count of beneficial bacteria in the intestine.